NBF.F NOLATO AB SER.B
- Market cap
- EUR 1.27B
- P/E
- 20.4x
- P/B
- 2.34x
- ROE
- 11.7%
- Dividend yield
- 3.38%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NBF.F undervalued?
Graham numberNBF.F trades 45.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NOLATO AB SER.B fundamental analysis
No fundamental analysis for NOLATO AB SER.B yet.
NOLATO AB SER.B stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NOLATO AB SER.B
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste …
Full company profileNOLATO AB SER.B financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
NOLATO AB SER.B annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 10.8B | 9.55B | 9.66B | 9.46B | 9.75B |
| Gross Profit | 1.43B | 1.34B | 1.61B | 1.73B | 1.77B |
| Operating Income | 838M | 660M | 897M | 983M | 972M |
| EBITDA | 1.48B | 1.27B | 1.51B | 1.60B | 972M |
| Net Income | 697M | 435M | 658M | 777M | 696M |
| EPS | 2.59 | 1.61 | 2.44 | 2.88 | 2.58 |
| Balance Sheet | |||||
| Total Assets | 10.0B | 9.30B | 9.69B | 9.28B | 11.2B |
| Total Liabilities | 4.62B | 4.13B | 3.95B | 3.75B | 5.21B |
| Shareholders' Equity | 5.39B | 5.17B | 5.74B | 5.53B | 5.97B |
| Cash & Short-term Investments | 1.01B | 688M | 672M | 482M | 584M |
| Cash Flow | |||||
| Operating Cash Flow | 406M | 781M | 1.38B | 1.06B | 1.13B |
| Capital Expenditure | 455M | 430M | 640M | 789M | 0.00 |
| Free Cash Flow | -49.0M | 351M | 1.38B | 273M | 1.13B |
| Ratios | |||||
| ROE | 12.9% | 8.4% | 11.5% | 14.0% | 11.7% |
| ROA | 7.0% | 4.7% | 6.8% | 8.4% | 6.2% |
| Net Profit Margin | 6.5% | 4.6% | 6.8% | 8.2% | 7.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
NOLATO AB SER.B dividends
- Dividend yield
- 3.38%
- Forward dividend
- 0.16 EUR
- Payout ratio
- 52.0%
- Ex-dividend date
- May 7, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | SEK 404M | 1.50 | 52.0% |
| 2024 | SEK 404M | 1.50 | 61.4% |
| 2023 | SEK 512M | 1.90 | 117.7% |
| 2022 | SEK 512M | 1.90 | 73.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 10:1 on May 12, 2021.
Who owns NOLATO AB SER.B
- Insiders 20.47%
- Institutions 58.95%
- Public & others 20.58%
- Shares outstanding 242M
- Free float 150M
NOLATO AB SER.B company profile
- Company name
- NOLATO AB SER.B
- Ticker
- NBF.F
- ISIN
- SE0015962477
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Industrial Conglomerates
- Employees
- 5,755
- Fiscal year end
- December
- Address
- Nolatovägen 32, Torekov, Sweden, 269 78
- Phone
- 46 4 31 44 22 90
- Website
- nolato.com
About NOLATO AB SER.B
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste under the Compatherm brand; Autolys M products, deep well plates, microtubes, PCR/qPCR products, pipettes and slim-line pipette tips, vial HP, and quality grades under the TreffLab by Nolato; and electromagnetic compatibility (EMC) products, including Compashield molded and extruded electromagnetic interference (EMI) shielding gaskets, Trishield, and MIL SPEC EMI shielding products. In addition, the company offers laboratory products, such as boxes with integrated lids; containers with hinged lids; sampling and transport tubes; spoons and cups; disposable tubes and containers; test tubes and ergonomic caps; and containers, vials, and slide tubes with push on lids. Further, it provides injection molding of plastic and silicone, injection blow molding, scientific and ceramic injection molding, dip and compression molding, and micro molding; extrusion and silicone sponge extrusion technologies; thermal management; decoration and cutting technologies; cleanroom production; assembly solutions; design and virtual prototyping solutions; and tool manufacturing. It serves medical technology, pharmaceutical, consumer electronics, telecom, automotive, hygiene, and other industrial sectors. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was founded in 1938 and is headquartered in Torekov, Sweden.
NOLATO AB SER.B management
10- Mr. Per-Ola Holmstrom MBAExecutive VP & CFO · born 1964
- Mr. Christer Wahlquist MBA, MESenior Advisor · born 1971
- Mr. Anders BjorklundPresident & CEO · born 1970
- Mr. Glenn SvedbergGroup Sustainability Director & Technology Director · born 1965
- Mr. Mats HåkanssonGroup Corporate Communication Manager
- Mr. Dan WongManaging Director of Nolato Lovepac Converting
- Mr. Johan IvebergPresident of Medical Solutions · born 1969
- Thomas HofflanderManaging Director of Nolato Beijing Medical & Nolato Beijing
- Olof PetterssonManaging Director of Nolato Gota & Nolato Plastteknik
- Henrik EnokssonManaging Director of Nolato Lövepac